nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—melanoma	0.299	1	CbGaD
Promethazine—CHRM5—skin epidermis—melanoma	0.008	0.0808	CbGeAlD
Promethazine—CALM2—ear—melanoma	0.00593	0.0599	CbGeAlD
Promethazine—CALM1—ear—melanoma	0.0059	0.0596	CbGeAlD
Promethazine—Paralysis—Vemurafenib—melanoma	0.00534	0.0358	CcSEcCtD
Promethazine—HTR2A—hindlimb—melanoma	0.00372	0.0376	CbGeAlD
Promethazine—HTR2A—appendage—melanoma	0.00319	0.0322	CbGeAlD
Promethazine—CALM2—endothelium—melanoma	0.00318	0.0321	CbGeAlD
Promethazine—CALM1—endothelium—melanoma	0.00316	0.0319	CbGeAlD
Promethazine—CALM2—hair follicle—melanoma	0.00313	0.0316	CbGeAlD
Promethazine—Photosensitivity—Vemurafenib—melanoma	0.00307	0.0206	CcSEcCtD
Promethazine—CALM2—blood vessel—melanoma	0.00293	0.0296	CbGeAlD
Promethazine—CALM1—blood vessel—melanoma	0.00292	0.0295	CbGeAlD
Promethazine—CHRM5—eye—melanoma	0.00285	0.0288	CbGeAlD
Promethazine—Necrosis—Dactinomycin—melanoma	0.00267	0.0179	CcSEcCtD
Promethazine—Extravasation—Bleomycin—melanoma	0.00258	0.0173	CcSEcCtD
Promethazine—Extrapyramidal disorder—Temozolomide—melanoma	0.00252	0.0169	CcSEcCtD
Promethazine—Necrosis—Carmustine—melanoma	0.0025	0.0168	CcSEcCtD
Promethazine—Abscess—Carmustine—melanoma	0.00248	0.0166	CcSEcCtD
Promethazine—CHRM5—skin of body—melanoma	0.00248	0.025	CbGeAlD
Promethazine—Extravasation—Dactinomycin—melanoma	0.0024	0.0161	CcSEcCtD
Promethazine—Extravasation—Carmustine—melanoma	0.00225	0.0151	CcSEcCtD
Promethazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00213	0.0143	CcSEcCtD
Promethazine—CALM2—neck—melanoma	0.0021	0.0212	CbGeAlD
Promethazine—CALM1—neck—melanoma	0.00209	0.0211	CbGeAlD
Promethazine—CHRM4—head—melanoma	0.00207	0.0209	CbGeAlD
Promethazine—Coordination abnormal—Carmustine—melanoma	0.002	0.0134	CcSEcCtD
Promethazine—CALM3—eye—melanoma	0.00199	0.0201	CbGeAlD
Promethazine—Aplastic anaemia—Dactinomycin—melanoma	0.00197	0.0132	CcSEcCtD
Promethazine—CALM3—retina—melanoma	0.00197	0.0199	CbGeAlD
Promethazine—Injection site reaction—Carmustine—melanoma	0.00195	0.0131	CcSEcCtD
Promethazine—Coordination abnormal—Temozolomide—melanoma	0.00193	0.013	CcSEcCtD
Promethazine—HTR2A—endothelium—melanoma	0.00193	0.0195	CbGeAlD
Promethazine—Phlebitis—Bleomycin—melanoma	0.00189	0.0127	CcSEcCtD
Promethazine—Disorientation—Bleomycin—melanoma	0.00182	0.0122	CcSEcCtD
Promethazine—Coma—Carmustine—melanoma	0.00179	0.012	CcSEcCtD
Promethazine—Aplastic anaemia—Temozolomide—melanoma	0.00178	0.0119	CcSEcCtD
Promethazine—HTR2A—blood vessel—melanoma	0.00178	0.0179	CbGeAlD
Promethazine—Phlebitis—Dactinomycin—melanoma	0.00177	0.0119	CcSEcCtD
Promethazine—Phlebitis—Carmustine—melanoma	0.00165	0.0111	CcSEcCtD
Promethazine—Thrombophlebitis—Carmustine—melanoma	0.00165	0.011	CcSEcCtD
Promethazine—Erythema—Vemurafenib—melanoma	0.00162	0.0109	CcSEcCtD
Promethazine—CHRM5—head—melanoma	0.00162	0.0163	CbGeAlD
Promethazine—Swelling—Carmustine—melanoma	0.00162	0.0108	CcSEcCtD
Promethazine—Necrosis—Docetaxel—melanoma	0.00161	0.0108	CcSEcCtD
Promethazine—Thrombophlebitis—Temozolomide—melanoma	0.00159	0.0107	CcSEcCtD
Promethazine—CALM3—mammalian vulva—melanoma	0.00158	0.0159	CbGeAlD
Promethazine—CALM2—eye—melanoma	0.00156	0.0158	CbGeAlD
Promethazine—CALM1—eye—melanoma	0.00155	0.0157	CbGeAlD
Promethazine—CALM2—retina—melanoma	0.00155	0.0156	CbGeAlD
Promethazine—CALM1—retina—melanoma	0.00154	0.0155	CbGeAlD
Promethazine—Nasal congestion—Temozolomide—melanoma	0.00151	0.0101	CcSEcCtD
Promethazine—Extravasation—Docetaxel—melanoma	0.00145	0.0097	CcSEcCtD
Promethazine—DRD2—eye—melanoma	0.00143	0.0145	CbGeAlD
Promethazine—Diplopia—Carmustine—melanoma	0.00142	0.00956	CcSEcCtD
Promethazine—DRD2—retina—melanoma	0.00142	0.0144	CbGeAlD
Promethazine—Diplopia—Temozolomide—melanoma	0.00138	0.00924	CcSEcCtD
Promethazine—CALM2—skin of body—melanoma	0.00136	0.0137	CbGeAlD
Promethazine—CALM1—skin of body—melanoma	0.00135	0.0136	CbGeAlD
Promethazine—Anaphylactic shock—Vemurafenib—melanoma	0.00132	0.00888	CcSEcCtD
Promethazine—HTR2A—neck—melanoma	0.00127	0.0128	CbGeAlD
Promethazine—Injection site reaction—Docetaxel—melanoma	0.00125	0.00841	CcSEcCtD
Promethazine—CALM2—mammalian vulva—melanoma	0.00124	0.0125	CbGeAlD
Promethazine—Hypotension—Vemurafenib—melanoma	0.00124	0.0083	CcSEcCtD
Promethazine—CALM1—mammalian vulva—melanoma	0.00123	0.0124	CbGeAlD
Promethazine—ABCB1—blood vessel—melanoma	0.00116	0.0118	CbGeAlD
Promethazine—Decreased appetite—Vemurafenib—melanoma	0.00115	0.00772	CcSEcCtD
Promethazine—Fatigue—Vemurafenib—melanoma	0.00114	0.00766	CcSEcCtD
Promethazine—HRH1—eye—melanoma	0.00113	0.0114	CbGeAlD
Promethazine—Constipation—Vemurafenib—melanoma	0.00113	0.0076	CcSEcCtD
Promethazine—CHRM2—head—melanoma	0.00111	0.0112	CbGeAlD
Promethazine—Depression—Carmustine—melanoma	0.00109	0.00734	CcSEcCtD
Promethazine—Agranulocytosis—Dactinomycin—melanoma	0.00109	0.00734	CcSEcCtD
Promethazine—Photosensitivity reaction—Temozolomide—melanoma	0.00109	0.00729	CcSEcCtD
Promethazine—Phlebitis—Docetaxel—melanoma	0.00106	0.00713	CcSEcCtD
Promethazine—Depression—Temozolomide—melanoma	0.00106	0.0071	CcSEcCtD
Promethazine—Thrombophlebitis—Docetaxel—melanoma	0.00106	0.0071	CcSEcCtD
Promethazine—Swelling—Docetaxel—melanoma	0.00104	0.00696	CcSEcCtD
Promethazine—CHRM1—head—melanoma	0.00101	0.0102	CbGeAlD
Promethazine—CYP2B6—skin of body—melanoma	0.00101	0.0102	CbGeAlD
Promethazine—Erythema—Bleomycin—melanoma	0.000983	0.00659	CcSEcCtD
Promethazine—Hallucination—Carmustine—melanoma	0.000981	0.00658	CcSEcCtD
Promethazine—Asthenia—Vemurafenib—melanoma	0.00095	0.00637	CcSEcCtD
Promethazine—Hallucination—Temozolomide—melanoma	0.000948	0.00636	CcSEcCtD
Promethazine—HTR2A—eye—melanoma	0.000946	0.00955	CbGeAlD
Promethazine—HTR2A—retina—melanoma	0.000938	0.00947	CbGeAlD
Promethazine—Pruritus—Vemurafenib—melanoma	0.000937	0.00628	CcSEcCtD
Promethazine—Erythema—Dactinomycin—melanoma	0.000917	0.00615	CcSEcCtD
Promethazine—Diarrhoea—Vemurafenib—melanoma	0.000906	0.00608	CcSEcCtD
Promethazine—CHRM3—head—melanoma	0.000905	0.00913	CbGeAlD
Promethazine—HRH1—mammalian vulva—melanoma	0.000899	0.00907	CbGeAlD
Promethazine—Tinnitus—Temozolomide—melanoma	0.000888	0.00596	CcSEcCtD
Promethazine—CALM2—head—melanoma	0.000886	0.00894	CbGeAlD
Promethazine—CALM1—head—melanoma	0.000882	0.0089	CbGeAlD
Promethazine—Arrhythmia—Carmustine—melanoma	0.000881	0.00591	CcSEcCtD
Promethazine—Leukopenia—Bleomycin—melanoma	0.00088	0.0059	CcSEcCtD
Promethazine—Dizziness—Vemurafenib—melanoma	0.000876	0.00587	CcSEcCtD
Promethazine—Erythema—Carmustine—melanoma	0.000858	0.00576	CcSEcCtD
Promethazine—Rash—Vemurafenib—melanoma	0.000835	0.0056	CcSEcCtD
Promethazine—Dermatitis—Vemurafenib—melanoma	0.000834	0.0056	CcSEcCtD
Promethazine—ADRA1A—head—melanoma	0.000831	0.00839	CbGeAlD
Promethazine—Headache—Vemurafenib—melanoma	0.00083	0.00556	CcSEcCtD
Promethazine—Erythema—Temozolomide—melanoma	0.000829	0.00556	CcSEcCtD
Promethazine—Leukopenia—Dactinomycin—melanoma	0.000821	0.0055	CcSEcCtD
Promethazine—DRD2—head—melanoma	0.000814	0.00822	CbGeAlD
Promethazine—Confusional state—Bleomycin—melanoma	0.000809	0.00543	CcSEcCtD
Promethazine—Vision blurred—Carmustine—melanoma	0.000809	0.00542	CcSEcCtD
Promethazine—Tremor—Carmustine—melanoma	0.000804	0.00539	CcSEcCtD
Promethazine—Anaphylactic shock—Bleomycin—melanoma	0.000802	0.00538	CcSEcCtD
Promethazine—Oedema—Bleomycin—melanoma	0.000802	0.00538	CcSEcCtD
Promethazine—CALM3—lymph node—melanoma	0.00079	0.00797	CbGeAlD
Promethazine—Agitation—Carmustine—melanoma	0.000789	0.00529	CcSEcCtD
Promethazine—Thrombocytopenia—Bleomycin—melanoma	0.000786	0.00527	CcSEcCtD
Promethazine—Vision blurred—Temozolomide—melanoma	0.000781	0.00524	CcSEcCtD
Promethazine—Tremor—Temozolomide—melanoma	0.000777	0.00521	CcSEcCtD
Promethazine—Leukopenia—Carmustine—melanoma	0.000768	0.00515	CcSEcCtD
Promethazine—Agitation—Temozolomide—melanoma	0.000762	0.00511	CcSEcCtD
Promethazine—Hypotension—Bleomycin—melanoma	0.00075	0.00503	CcSEcCtD
Promethazine—Oedema—Dactinomycin—melanoma	0.000748	0.00502	CcSEcCtD
Promethazine—Convulsion—Carmustine—melanoma	0.000743	0.00499	CcSEcCtD
Promethazine—Leukopenia—Temozolomide—melanoma	0.000742	0.00498	CcSEcCtD
Promethazine—Palpitations—Temozolomide—melanoma	0.000733	0.00492	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—melanoma	0.000733	0.00491	CcSEcCtD
Promethazine—Anxiety—Carmustine—melanoma	0.000728	0.00488	CcSEcCtD
Promethazine—Convulsion—Temozolomide—melanoma	0.000718	0.00482	CcSEcCtD
Promethazine—Confusional state—Carmustine—melanoma	0.000706	0.00474	CcSEcCtD
Promethazine—Anxiety—Temozolomide—melanoma	0.000704	0.00472	CcSEcCtD
Promethazine—Oedema—Carmustine—melanoma	0.0007	0.0047	CcSEcCtD
Promethazine—Decreased appetite—Bleomycin—melanoma	0.000697	0.00468	CcSEcCtD
Promethazine—Dry mouth—Temozolomide—melanoma	0.00069	0.00463	CcSEcCtD
Promethazine—Jaundice—Docetaxel—melanoma	0.000688	0.00461	CcSEcCtD
Promethazine—Pain—Bleomycin—melanoma	0.000686	0.0046	CcSEcCtD
Promethazine—Thrombocytopenia—Carmustine—melanoma	0.000686	0.0046	CcSEcCtD
Promethazine—Tachycardia—Carmustine—melanoma	0.000683	0.00458	CcSEcCtD
Promethazine—Confusional state—Temozolomide—melanoma	0.000682	0.00458	CcSEcCtD
Promethazine—Anaphylactic shock—Temozolomide—melanoma	0.000677	0.00454	CcSEcCtD
Promethazine—Oedema—Temozolomide—melanoma	0.000677	0.00454	CcSEcCtD
Promethazine—Thrombocytopenia—Temozolomide—melanoma	0.000663	0.00444	CcSEcCtD
Promethazine—Feeling abnormal—Bleomycin—melanoma	0.000661	0.00443	CcSEcCtD
Promethazine—Agranulocytosis—Docetaxel—melanoma	0.000659	0.00442	CcSEcCtD
Promethazine—CYP2B6—head—melanoma	0.000658	0.00665	CbGeAlD
Promethazine—Hypotension—Carmustine—melanoma	0.000654	0.00439	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—melanoma	0.00065	0.00436	CcSEcCtD
Promethazine—Fatigue—Dactinomycin—melanoma	0.000645	0.00433	CcSEcCtD
Promethazine—HRH1—head—melanoma	0.000643	0.00649	CbGeAlD
Promethazine—Pain—Dactinomycin—melanoma	0.00064	0.00429	CcSEcCtD
Promethazine—Insomnia—Carmustine—melanoma	0.000633	0.00425	CcSEcCtD
Promethazine—Somnolence—Carmustine—melanoma	0.000623	0.00418	CcSEcCtD
Promethazine—CALM2—lymph node—melanoma	0.00062	0.00626	CbGeAlD
Promethazine—CALM1—lymph node—melanoma	0.000617	0.00623	CbGeAlD
Promethazine—Feeling abnormal—Dactinomycin—melanoma	0.000617	0.00414	CcSEcCtD
Promethazine—ABCB1—retina—melanoma	0.000614	0.0062	CbGeAlD
Promethazine—Insomnia—Temozolomide—melanoma	0.000612	0.00411	CcSEcCtD
Promethazine—Decreased appetite—Carmustine—melanoma	0.000609	0.00408	CcSEcCtD
Promethazine—Somnolence—Temozolomide—melanoma	0.000602	0.00404	CcSEcCtD
Promethazine—Constipation—Carmustine—melanoma	0.000599	0.00402	CcSEcCtD
Promethazine—Pain—Carmustine—melanoma	0.000599	0.00402	CcSEcCtD
Promethazine—Dyspepsia—Temozolomide—melanoma	0.000596	0.004	CcSEcCtD
Promethazine—Decreased appetite—Temozolomide—melanoma	0.000588	0.00395	CcSEcCtD
Promethazine—Fatigue—Temozolomide—melanoma	0.000583	0.00391	CcSEcCtD
Promethazine—Constipation—Temozolomide—melanoma	0.000579	0.00388	CcSEcCtD
Promethazine—Pain—Temozolomide—melanoma	0.000579	0.00388	CcSEcCtD
Promethazine—Feeling abnormal—Carmustine—melanoma	0.000577	0.00387	CcSEcCtD
Promethazine—Asthenia—Bleomycin—melanoma	0.000576	0.00386	CcSEcCtD
Promethazine—Pruritus—Bleomycin—melanoma	0.000568	0.00381	CcSEcCtD
Promethazine—Arrhythmia—Docetaxel—melanoma	0.000566	0.0038	CcSEcCtD
Promethazine—Feeling abnormal—Temozolomide—melanoma	0.000558	0.00374	CcSEcCtD
Promethazine—Erythema—Docetaxel—melanoma	0.000551	0.0037	CcSEcCtD
Promethazine—HTR2A—head—melanoma	0.000537	0.00542	CbGeAlD
Promethazine—Asthenia—Dactinomycin—melanoma	0.000537	0.0036	CcSEcCtD
Promethazine—Muscle spasms—Docetaxel—melanoma	0.00053	0.00356	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—melanoma	0.000512	0.00343	CcSEcCtD
Promethazine—Rash—Bleomycin—melanoma	0.000506	0.00339	CcSEcCtD
Promethazine—Dermatitis—Bleomycin—melanoma	0.000505	0.00339	CcSEcCtD
Promethazine—Asthenia—Carmustine—melanoma	0.000502	0.00337	CcSEcCtD
Promethazine—Syncope—Docetaxel—melanoma	0.000495	0.00332	CcSEcCtD
Promethazine—Leukopenia—Docetaxel—melanoma	0.000494	0.00331	CcSEcCtD
Promethazine—ABCB1—mammalian vulva—melanoma	0.000492	0.00497	CbGeAlD
Promethazine—CYP2D6—head—melanoma	0.000489	0.00494	CbGeAlD
Promethazine—Palpitations—Docetaxel—melanoma	0.000487	0.00327	CcSEcCtD
Promethazine—Asthenia—Temozolomide—melanoma	0.000486	0.00326	CcSEcCtD
Promethazine—Loss of consciousness—Docetaxel—melanoma	0.000485	0.00325	CcSEcCtD
Promethazine—Diarrhoea—Carmustine—melanoma	0.000479	0.00321	CcSEcCtD
Promethazine—Pruritus—Temozolomide—melanoma	0.000479	0.00321	CcSEcCtD
Promethazine—Convulsion—Docetaxel—melanoma	0.000478	0.0032	CcSEcCtD
Promethazine—Rash—Dactinomycin—melanoma	0.000472	0.00316	CcSEcCtD
Promethazine—Dizziness—Carmustine—melanoma	0.000463	0.00311	CcSEcCtD
Promethazine—Diarrhoea—Temozolomide—melanoma	0.000463	0.00311	CcSEcCtD
Promethazine—Dry mouth—Docetaxel—melanoma	0.000459	0.00308	CcSEcCtD
Promethazine—Confusional state—Docetaxel—melanoma	0.000454	0.00304	CcSEcCtD
Promethazine—HRH1—lymph node—melanoma	0.00045	0.00455	CbGeAlD
Promethazine—Oedema—Docetaxel—melanoma	0.00045	0.00302	CcSEcCtD
Promethazine—Anaphylactic shock—Docetaxel—melanoma	0.00045	0.00302	CcSEcCtD
Promethazine—Dizziness—Temozolomide—melanoma	0.000448	0.003	CcSEcCtD
Promethazine—Orphenadrine—SCN10A—melanoma	0.000447	0.157	CrCbGaD
Promethazine—Shock—Docetaxel—melanoma	0.000443	0.00297	CcSEcCtD
Promethazine—Rash—Carmustine—melanoma	0.000442	0.00296	CcSEcCtD
Promethazine—Dermatitis—Carmustine—melanoma	0.000441	0.00296	CcSEcCtD
Promethazine—Thrombocytopenia—Docetaxel—melanoma	0.000441	0.00296	CcSEcCtD
Promethazine—Tachycardia—Docetaxel—melanoma	0.000439	0.00295	CcSEcCtD
Promethazine—Headache—Carmustine—melanoma	0.000439	0.00294	CcSEcCtD
Promethazine—Rash—Temozolomide—melanoma	0.000427	0.00286	CcSEcCtD
Promethazine—Dermatitis—Temozolomide—melanoma	0.000426	0.00286	CcSEcCtD
Promethazine—Headache—Temozolomide—melanoma	0.000424	0.00284	CcSEcCtD
Promethazine—Hypotension—Docetaxel—melanoma	0.000421	0.00282	CcSEcCtD
Promethazine—Insomnia—Docetaxel—melanoma	0.000407	0.00273	CcSEcCtD
Promethazine—Somnolence—Docetaxel—melanoma	0.0004	0.00268	CcSEcCtD
Promethazine—Dyspepsia—Docetaxel—melanoma	0.000396	0.00266	CcSEcCtD
Promethazine—Decreased appetite—Docetaxel—melanoma	0.000391	0.00262	CcSEcCtD
Promethazine—Fatigue—Docetaxel—melanoma	0.000388	0.0026	CcSEcCtD
Promethazine—Pain—Docetaxel—melanoma	0.000385	0.00258	CcSEcCtD
Promethazine—Constipation—Docetaxel—melanoma	0.000385	0.00258	CcSEcCtD
Promethazine—Feeling abnormal—Docetaxel—melanoma	0.000371	0.00249	CcSEcCtD
Promethazine—ABCB1—head—melanoma	0.000352	0.00355	CbGeAlD
Promethazine—Asthenia—Docetaxel—melanoma	0.000323	0.00217	CcSEcCtD
Promethazine—Pruritus—Docetaxel—melanoma	0.000318	0.00214	CcSEcCtD
Promethazine—Diarrhoea—Docetaxel—melanoma	0.000308	0.00207	CcSEcCtD
Promethazine—Dizziness—Docetaxel—melanoma	0.000298	0.002	CcSEcCtD
Promethazine—Rash—Docetaxel—melanoma	0.000284	0.0019	CcSEcCtD
Promethazine—Dermatitis—Docetaxel—melanoma	0.000284	0.0019	CcSEcCtD
Promethazine—Headache—Docetaxel—melanoma	0.000282	0.00189	CcSEcCtD
Promethazine—ABCB1—lymph node—melanoma	0.000246	0.00249	CbGeAlD
Promethazine—Oxcarbazepine—ALB—melanoma	0.000209	0.0735	CrCbGaD
Promethazine—Diltiazem—ABCB1—melanoma	0.000183	0.0642	CrCbGaD
Promethazine—Triflupromazine—ABCB1—melanoma	0.000163	0.0572	CrCbGaD
Promethazine—Acepromazine—ALB—melanoma	0.000158	0.0555	CrCbGaD
Promethazine—Thioproperazine—ALB—melanoma	0.000155	0.0542	CrCbGaD
Promethazine—Pipotiazine—ALB—melanoma	0.000152	0.0534	CrCbGaD
Promethazine—Carbamazepine—ABCB1—melanoma	0.000136	0.0478	CrCbGaD
Promethazine—Clomipramine—ALB—melanoma	0.00012	0.0422	CrCbGaD
Promethazine—Clomipramine—ABCB1—melanoma	0.000115	0.0403	CrCbGaD
Promethazine—Chlorprothixene—ABCB1—melanoma	0.000114	0.0401	CrCbGaD
Promethazine—Trimipramine—ABCB1—melanoma	0.000106	0.037	CrCbGaD
Promethazine—Doxepin—ABCB1—melanoma	0.000101	0.0353	CrCbGaD
Promethazine—Trifluoperazine—ABCB1—melanoma	0.0001	0.0352	CrCbGaD
Promethazine—Methadone—ABCB1—melanoma	0.0001	0.0351	CrCbGaD
Promethazine—Desipramine—ABCB1—melanoma	9.23e-05	0.0324	CrCbGaD
Promethazine—Chlorpromazine—ALB—melanoma	8.25e-05	0.0289	CrCbGaD
Promethazine—Amitriptyline—ALB—melanoma	8.15e-05	0.0286	CrCbGaD
Promethazine—Chlorpromazine—ABCB1—melanoma	7.87e-05	0.0276	CrCbGaD
Promethazine—Imipramine—ABCB1—melanoma	7.83e-05	0.0275	CrCbGaD
Promethazine—Amitriptyline—ABCB1—melanoma	7.78e-05	0.0273	CrCbGaD
Promethazine—CALM1—Metabolism—PTEN—melanoma	5.53e-06	1.23e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—melanoma	5.53e-06	1.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PIK3CA—melanoma	5.52e-06	1.23e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PIK3CA—melanoma	5.52e-06	1.23e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—AKT1—melanoma	5.52e-06	1.23e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—AKT1—melanoma	5.5e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MDM2—melanoma	5.5e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MDM2—melanoma	5.5e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—melanoma	5.49e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—melanoma	5.49e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—melanoma	5.49e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—melanoma	5.49e-06	1.22e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB2—melanoma	5.42e-06	1.21e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB2—melanoma	5.42e-06	1.21e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CD—melanoma	5.42e-06	1.21e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CD—melanoma	5.38e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK1—melanoma	5.37e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK1—melanoma	5.37e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—melanoma	5.37e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—melanoma	5.37e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CB—melanoma	5.35e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CB—melanoma	5.35e-06	1.19e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ALB—melanoma	5.35e-06	1.19e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—melanoma	5.32e-06	1.18e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—melanoma	5.31e-06	1.18e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—melanoma	5.31e-06	1.18e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ALB—melanoma	5.31e-06	1.18e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—melanoma	5.29e-06	1.18e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—melanoma	5.28e-06	1.17e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—melanoma	5.24e-06	1.17e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—melanoma	5.24e-06	1.16e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—NRAS—melanoma	5.22e-06	1.16e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—melanoma	5.22e-06	1.16e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—melanoma	5.2e-06	1.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1B—melanoma	5.19e-06	1.15e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—melanoma	5.19e-06	1.15e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—melanoma	5.17e-06	1.15e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—melanoma	5.16e-06	1.15e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—melanoma	5.15e-06	1.15e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—melanoma	5.14e-06	1.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—melanoma	5.14e-06	1.14e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—melanoma	5.14e-06	1.14e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—NRAS—melanoma	5.14e-06	1.14e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—NRAS—melanoma	5.13e-06	1.14e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—melanoma	5.12e-06	1.14e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—NRAS—melanoma	5.11e-06	1.14e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—melanoma	5.11e-06	1.14e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—melanoma	5.11e-06	1.14e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—melanoma	5.11e-06	1.14e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—melanoma	5.11e-06	1.14e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—NRAS—melanoma	5.1e-06	1.13e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—melanoma	5.09e-06	1.13e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—melanoma	5.09e-06	1.13e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—melanoma	5.08e-06	1.13e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—melanoma	5.08e-06	1.13e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—melanoma	5.07e-06	1.13e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—melanoma	5.07e-06	1.13e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—melanoma	5.06e-06	1.12e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—melanoma	5.06e-06	1.12e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—melanoma	5.05e-06	1.12e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—melanoma	5.05e-06	1.12e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—NRAS—melanoma	5.05e-06	1.12e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—melanoma	5.04e-06	1.12e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—NRAS—melanoma	5.03e-06	1.12e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1B—melanoma	5.02e-06	1.12e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1B—melanoma	5.02e-06	1.12e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CB—melanoma	5.02e-06	1.11e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK3—melanoma	5e-06	1.11e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—melanoma	4.97e-06	1.1e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—melanoma	4.95e-06	1.1e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—melanoma	4.92e-06	1.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—melanoma	4.92e-06	1.09e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK3—melanoma	4.92e-06	1.09e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—melanoma	4.92e-06	1.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—melanoma	4.92e-06	1.09e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK3—melanoma	4.91e-06	1.09e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—melanoma	4.91e-06	1.09e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—melanoma	4.9e-06	1.09e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK3—melanoma	4.9e-06	1.09e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—melanoma	4.89e-06	1.09e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—melanoma	4.89e-06	1.09e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK3—melanoma	4.88e-06	1.08e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—melanoma	4.87e-06	1.08e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK3—melanoma	4.83e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—melanoma	4.83e-06	1.07e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK3—melanoma	4.82e-06	1.07e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—melanoma	4.82e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—melanoma	4.82e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—melanoma	4.81e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1A—melanoma	4.79e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—melanoma	4.79e-06	1.07e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—melanoma	4.79e-06	1.07e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—melanoma	4.79e-06	1.06e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—melanoma	4.78e-06	1.06e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—melanoma	4.78e-06	1.06e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—melanoma	4.76e-06	1.06e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK1—melanoma	4.76e-06	1.06e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NFKB1—melanoma	4.76e-06	1.06e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—melanoma	4.76e-06	1.06e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—melanoma	4.75e-06	1.05e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—melanoma	4.75e-06	1.05e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—melanoma	4.75e-06	1.05e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CB—melanoma	4.73e-06	1.05e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—melanoma	4.7e-06	1.04e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—melanoma	4.69e-06	1.04e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—melanoma	4.69e-06	1.04e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CB—melanoma	4.69e-06	1.04e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK1—melanoma	4.68e-06	1.04e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—melanoma	4.68e-06	1.04e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—melanoma	4.68e-06	1.04e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK1—melanoma	4.67e-06	1.04e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—melanoma	4.67e-06	1.04e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—melanoma	4.67e-06	1.04e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—melanoma	4.67e-06	1.04e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—melanoma	4.66e-06	1.04e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—melanoma	4.66e-06	1.04e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—melanoma	4.66e-06	1.04e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK1—melanoma	4.66e-06	1.04e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—melanoma	4.66e-06	1.04e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—melanoma	4.65e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—melanoma	4.65e-06	1.03e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK1—melanoma	4.64e-06	1.03e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—melanoma	4.64e-06	1.03e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—melanoma	4.64e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1A—melanoma	4.64e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1A—melanoma	4.64e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—melanoma	4.63e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—melanoma	4.63e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—melanoma	4.62e-06	1.03e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NFKB1—melanoma	4.6e-06	1.02e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NFKB1—melanoma	4.6e-06	1.02e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK1—melanoma	4.6e-06	1.02e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—melanoma	4.6e-06	1.02e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK1—melanoma	4.59e-06	1.02e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—melanoma	4.58e-06	1.02e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—melanoma	4.51e-06	1e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—melanoma	4.51e-06	1e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—melanoma	4.5e-06	9.99e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—melanoma	4.47e-06	9.93e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—melanoma	4.47e-06	9.93e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—melanoma	4.46e-06	9.91e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—melanoma	4.42e-06	9.83e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—melanoma	4.41e-06	9.81e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—melanoma	4.4e-06	9.78e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—melanoma	4.39e-06	9.75e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—melanoma	4.34e-06	9.65e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—melanoma	4.33e-06	9.63e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—melanoma	4.33e-06	9.63e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—melanoma	4.32e-06	9.6e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—melanoma	4.31e-06	9.58e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—melanoma	4.31e-06	9.58e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—melanoma	4.28e-06	9.51e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—NRAS—melanoma	4.27e-06	9.48e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—melanoma	4.27e-06	9.48e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—melanoma	4.26e-06	9.47e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—melanoma	4.18e-06	9.29e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—melanoma	4.18e-06	9.29e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—melanoma	4.15e-06	9.21e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—melanoma	4.14e-06	9.2e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—melanoma	4.14e-06	9.2e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—melanoma	4.13e-06	9.18e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—NRAS—melanoma	4.13e-06	9.17e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—NRAS—melanoma	4.13e-06	9.17e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—melanoma	4.13e-06	9.17e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—melanoma	4.13e-06	9.17e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—melanoma	4.12e-06	9.16e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—melanoma	4.12e-06	9.16e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK3—melanoma	4.09e-06	9.08e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—melanoma	4.08e-06	9.08e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—melanoma	4.06e-06	9.03e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—melanoma	4.05e-06	9.01e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—melanoma	4.05e-06	9e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—melanoma	4.04e-06	8.98e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—melanoma	4.03e-06	8.97e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—melanoma	4.03e-06	8.96e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—melanoma	4e-06	8.88e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—melanoma	3.99e-06	8.87e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	3.98e-06	8.84e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—melanoma	3.97e-06	8.83e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK3—melanoma	3.95e-06	8.78e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK3—melanoma	3.95e-06	8.78e-06	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—melanoma	3.94e-06	8.75e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—melanoma	3.94e-06	8.75e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—melanoma	3.93e-06	8.74e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—melanoma	3.92e-06	8.72e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—melanoma	3.91e-06	8.69e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—melanoma	3.9e-06	8.67e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—melanoma	3.9e-06	8.67e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—melanoma	3.9e-06	8.66e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK1—melanoma	3.89e-06	8.64e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—melanoma	3.89e-06	8.64e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—melanoma	3.86e-06	8.58e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—melanoma	3.85e-06	8.56e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—melanoma	3.84e-06	8.54e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—melanoma	3.84e-06	8.54e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—melanoma	3.82e-06	8.49e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—melanoma	3.81e-06	8.46e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—melanoma	3.81e-06	8.46e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK1—melanoma	3.76e-06	8.36e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK1—melanoma	3.76e-06	8.36e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—melanoma	3.76e-06	8.36e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—melanoma	3.76e-06	8.36e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—melanoma	3.76e-06	8.36e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—melanoma	3.75e-06	8.34e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—melanoma	3.74e-06	8.31e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—melanoma	3.73e-06	8.29e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—melanoma	3.69e-06	8.21e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—melanoma	3.68e-06	8.18e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—melanoma	3.67e-06	8.16e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—melanoma	3.66e-06	8.13e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—melanoma	3.6e-06	8e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—melanoma	3.59e-06	7.98e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—melanoma	3.58e-06	7.96e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—melanoma	3.57e-06	7.93e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—melanoma	3.55e-06	7.89e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—melanoma	3.55e-06	7.89e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—melanoma	3.53e-06	7.85e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—melanoma	3.52e-06	7.83e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—melanoma	3.39e-06	7.53e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—melanoma	3.37e-06	7.5e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—melanoma	3.37e-06	7.5e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—melanoma	3.32e-06	7.38e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—melanoma	3.31e-06	7.36e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—melanoma	3.3e-06	7.34e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—melanoma	3.3e-06	7.33e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—melanoma	3.29e-06	7.32e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—melanoma	3.26e-06	7.25e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—melanoma	3.26e-06	7.25e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—melanoma	3.26e-06	7.25e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—melanoma	3.26e-06	7.25e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—melanoma	3.25e-06	7.23e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—melanoma	3.19e-06	7.09e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—melanoma	3.19e-06	7.09e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—melanoma	3.16e-06	7.02e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—melanoma	3.16e-06	7.02e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—melanoma	3.12e-06	6.94e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—melanoma	3.06e-06	6.8e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—melanoma	3.02e-06	6.71e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—melanoma	3.02e-06	6.71e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—melanoma	2.99e-06	6.64e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—melanoma	2.89e-06	6.42e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—melanoma	2.89e-06	6.42e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—melanoma	2.88e-06	6.4e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—melanoma	2.86e-06	6.35e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—melanoma	2.76e-06	6.13e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—melanoma	2.67e-06	5.93e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—melanoma	2.67e-06	5.93e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—melanoma	2.5e-06	5.55e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—melanoma	2.35e-06	5.23e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—melanoma	2.33e-06	5.19e-06	CbGpPWpGaD
